Pro-inflammatory Cytokine & Chemokine Signature Profiling Service
Creative Biolabs moves beyond standard protein quantification by providing a deep-dive analysis of the "immune hubs" that drive disease pathology. Our service identifies synergistic interactions, allowing you to map the exact mechanism of action for your therapeutic leads. By quantifying these signatures, we assist in the early identification of drug-induced cytokine storms, provide data for stratification in "cold" vs. "hot" tumors, and offer high-sensitivity detection of low-abundance markers. Whether you are developing small molecules, antibody-drug conjugates, or checkpoint inhibitors, our profiling data provides the scientific clarity needed for rigorous target validation.
Scientific Foundation
Pro-inflammatory cytokines and chemokines are the primary orchestrators of the immune microenvironment, governing everything from acute cellular recruitment to chronic tissue remodeling. Extensive scientific literature confirms that static, single-protein measurements are insufficient for predicting complex biological outcomes in conditions like oncology or autoimmune disease. For instance, recent studies on the IL-6/STAT3 axis and organ-specific metastasis highlight that disease progression is driven by the dynamic interplay of signaling networks rather than isolated analytes. Our profiling service bridges this gap by mapping these interactions with high precision.
Comprehensive Profiling Solutions
To address the diverse needs of modern biopharmaceutical research, Creative Biolabs provides a modular and highly customizable suite of profiling solutions designed to capture the full spectrum of immune signaling:
Multiplexed Signature Panels
Access pre-validated or custom-built panels targeting up to 100 analytes, including key pro-inflammatory drivers, Th1/Th2/Th17 cytokines, and organ-specific chemokines (CXCL9, CXCL10, CCL20).
High-Sensitivity Digital Immunoassays
For projects requiring the detection of ultra-low abundance biomarkers in "immune-cold" environments, we offer digital counting technologies with sub-picogram sensitivity (femtogram/mL range).
Tumor Microenvironment (TME) Fractionation
Specialized profiling of tumor interstitial fluid, malignant ascites, and localized aspirates to distinguish between systemic inflammation and niche-specific immune evasion.
Longitudinal Monitoring & Pharmacodynamics
Integrated analysis of cytokine fluxes across multiple time points to evaluate drug half-life, target engagement, and the onset of resistance.
Advanced Bio-computational Analysis
Beyond raw data, we provide interaction modeling, cluster analysis, and pathway enrichment (KEGG/Reactome) to translate protein concentrations into functional biological insights.
Empower Your Lead Optimization with Custom Analyte Panels — Get Detailed Service Specifications
Workflow
To ensure maximum precision and reproducibility, our workflow is engineered to be comprehensive, transparent, and suitable for high-level visualization in regulatory dossiers.
Publication
This review examines immune checkpoint inhibitor (CPI) therapy for metastatic skin cancers, including melanoma, basal cell carcinoma, squamous cell carcinoma, and Merkel cell carcinoma. It highlights the need for predictive biomarkers such as tumor mutational burden, PD-L1 expression, and cytokine/chemokine profiles (e.g., IFN-γ, IL-6, IL-8) to improve treatment response, manage immune-related adverse events, and guide personalized immunotherapy.
Fig.1 The "physics" of the cancer immune response: a kinetic model from immune silence to checkpoint blockade. 1
Why Choose Us?
Choosing Creative Biolabs means partnering with a leader in cytokine biology that leverages over two decades of specialized expertise in protein engineering and high-resolution immunology. Unlike generalist service providers, we focus on "signature profiling," a method designed to detect non-linear interactions between cytokines that define biological outcomes and are often invisible to single-analyte assays. With a global footprint and a commitment to rigorous quality control, we ensure your data is generated using the most advanced high-throughput platforms available. We provide more than just data points; we deliver comprehensive biological narratives that empower your decision-making process during critical lead optimization stages.
Experience the Creative Biolabs Advantage — Request a Comprehensive Project Quote Today
FAQs
What is the primary advantage of 'signature profiling' over standard methods?
Standard methods measure individual proteins. Our profiling detects the interaction and ratio between multiple cytokines, providing a much more accurate biological "fingerprint" of the disease state.
Can you profile samples from 'cold' tumors with extremely low cytokine levels?
Yes, we utilize high-sensitivity digital platforms that can detect concentrations in the sub-picogram/mL range, ensuring data even from immunosuppressive samples.
Are custom panels available for specific disease areas?
Absolutely. Creative Biolabs can tailor panels for neuro-inflammation, cutaneous oncology, or systemic autoimmune disorders based on your specific therapeutic goals.
Customer Review
-
Enhanced Sensitivity
Using Creative Biolabs' profiling in our research has significantly facilitated the detection of low-abundance chemokines in metastasis models that were previously undetectable on standard platforms. The sensitivity is unmatched. - Dr. Mar*** S -
Accurate Stratification
The multiplexed signature analysis allowed us to distinguish between responders and non-responders in our trial months earlier than expected, saving significant resources. - Ph.D. Rob*** K
Related Services
To achieve a holistic understanding of your therapeutic candidate, Creative Biolabs recommends these complementary services:
Toxicity Assessment by Quantification of Amylase
Creative Biolabs provides amylase quantification services, utilizing enzymatic and chromogenic methods for toxicity assessment. We evaluate pancreatic/salivary damage and alpha-amylase inhibition to quantify metabolic kinetics and identify T2DM-targeted therapeutic leads.
Learn More →Monocyte Immunophenotyping Service
Creative Biolabs provides high-dimensional monocyte immunophenotyping, utilizing 20-color flow cytometry to resolve classical, non-classical, and intermediate subsets. We quantify activation and checkpoint markers to evaluate myeloid plasticity and TME-driven differentiation.
Learn More →How to Contact Creative Biolabs
Creative Biolabs provides the industry's most sophisticated service, combining 20+ years of expertise with high-throughput technology to identify the molecular drivers of your project's success. We ensure that your data is precise, actionable, and ready for the next stage of development.
Contact our scientific team today to discuss your project requirements and receive a customized profiling strategy.
Reference
- Bridge, J. A., et al. "Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer." Front Med (Lausanne) 5 (2018): 351. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fmed.2018.00351
Download our brochure